b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">32244867</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>22</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Print">2072-6694</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>12</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Mar</Month>\n                        <Day>20</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cancers</Title>\n                <ISOAbbreviation>Cancers (Basel)</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E731</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers12030731</ELocationID>\n            <Abstract>\n                <AbstractText>Receptor tyrosine kinases (RTKs) are key regulatory signaling proteins governing cancer cell growth and metastasis. During the last two decades, several molecules targeting RTKs were used in oncology as a first or second line therapy in different types of cancer. However, their effectiveness is limited by the appearance of resistance or adverse effects. In this review, we summarize the main features of RTKs and their inhibitors (RTKIs), their current use in oncology, and mechanisms of resistance. We also describe the technological advances of artificial intelligence, chemoproteomics, and microfluidics in elaborating powerful strategies that could be used in providing more efficient and selective small molecules inhibitors of RTKs. Finally, we discuss the interest of therapeutic combination of different RTKIs or with other molecules for personalized treatments, and the challenge for effective combination with less toxic and off-target effects.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Pottier</LastName>\n                    <ForeName>Charles</ForeName>\n                    <Initials>C</Initials>\n                    <Identifier Source="ORCID">0000-0002-0126-5612</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory of Tumor and Development Biology, GIGA-Cancer and GIGA-I3, GIGA-Research, University Hospital of Li\xc3\xa8ge, 4000 Li\xc3\xa8ge, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, University Hospital of Li\xc3\xa8ge, 4000 Li\xc3\xa8ge, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fresnais</LastName>\n                    <ForeName>Margaux</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital of Heidelberg, 69120 Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>German Cancer Consortium (DKTK)-German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gilon</LastName>\n                    <ForeName>Marie</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory of Tumor and Development Biology, GIGA-Cancer and GIGA-I3, GIGA-Research, University Hospital of Li\xc3\xa8ge, 4000 Li\xc3\xa8ge, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>J\xc3\xa9rusalem</LastName>\n                    <ForeName>Guy</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, University Hospital of Li\xc3\xa8ge, 4000 Li\xc3\xa8ge, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Longuesp\xc3\xa9e</LastName>\n                    <ForeName>R\xc3\xa9mi</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital of Heidelberg, 69120 Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sounni</LastName>\n                    <ForeName>Nor Eddine</ForeName>\n                    <Initials>NE</Initials>\n                    <Identifier Source="ORCID">0000-0001-9962-9236</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory of Tumor and Development Biology, GIGA-Cancer and GIGA-I3, GIGA-Research, University Hospital of Li\xc3\xa8ge, 4000 Li\xc3\xa8ge, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>20</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Cancers (Basel)</MedlineTA>\n            <NlmUniqueID>101526829</NlmUniqueID>\n            <ISSNLinking>2072-6694</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">cancer</Keyword>\n            <Keyword MajorTopicYN="N">oncology</Keyword>\n            <Keyword MajorTopicYN="N">pharmacology</Keyword>\n            <Keyword MajorTopicYN="N">tyrosine kinase inhibitors</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>16</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32244867</ArticleId>\n            <ArticleId IdType="pii">cancers12030731</ArticleId>\n            <ArticleId IdType="doi">10.3390/cancers12030731</ArticleId>\n            <ArticleId IdType="pmc">PMC7140093</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Lancet. 2013 Jan 26;381(9863):303-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23177514</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Syst. 2018 Mar 28;6(3):329-342.e6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29550255</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2019 May;30(5):871-873</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31987361</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2018 Mar;19(3):405-415</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29439857</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunol Rev. 2017 Mar;276(1):165-177</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28258690</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer. 2018 Feb 19;17(1):49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29455643</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Chem. 2013 Apr 11;56(7):3033-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23441572</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>World J Clin Oncol. 2011 Feb 10;2(2):80-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21603317</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharm Pharm Sci. 2019;22(1):37-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30636671</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Med. 2015 Jun;9(2):134-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25957263</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Graph Model. 2004 Oct;23(2):139-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15363456</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2019 Jun 28;10(1):2879</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31253767</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2019 Feb;19(2):65-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30647431</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Onco Targets Ther. 2016 Sep 23;9:5825-5837</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27713636</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2018 Sep;17(9):1871-1880</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29959200</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2018 Nov 06;19(11):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30404198</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2017 Jul 1;28(suppl_4):iv41-iv51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28881915</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2007 Mar;6(3):1159-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17363509</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cancer. 2019 Jan 29;10(5):1275-1287</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30854137</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2012 Jul 26;487(7408):500-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22763439</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Future Oncol. 2019 Sep;15(25):2905-2914</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31370698</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Pharmacol. 2015 Jun;172(11):2675-700</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25630872</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Discov. 2017 Jul;7(7):750-765</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28274958</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Adv Exp Med Biol. 2019;1163:253-278</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31707707</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunother Cancer. 2018 Oct 22;6(1):109</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30348216</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2018 Oct 1;29(Suppl 4):iv68-iv78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29846513</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Physiol. 2013 Apr;228(4):665-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23018746</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2017 Nov;18(11):1454-1466</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28958502</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J R Soc Interface. 2018 Apr;15(141):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29618526</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Carcinog. 2017 Jun;56(6):1531-1542</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28112438</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2010 Jun 25;141(7):1117-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20602996</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncologist. 2009 Apr;14(4):399-411</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19357226</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2017 Jul 14;18(7):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28708099</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Des Devel Ther. 2018 Oct 23;12:3549-3561</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30425456</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Biol Cell. 2015 Nov 5;26(22):3946-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26337386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>ESMO Open. 2016 May 11;1(3):e000060</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27843613</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2017 Dec 21;9(5):6630-6643</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29464099</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2018 Jul;17(7):1355-1364</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29967214</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6742-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19346489</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2018 Dec 1;24(23):6078-6097</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30076136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Medicina (Kaunas). 2019 Jul 28;55(8):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31357735</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Res. 2019 Jun;144:19-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30877063</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2013 Sep 20;31(27):3327-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23816960</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancers (Basel). 2019 May 28;11(6):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31141894</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2008 Feb 1;26(4):620-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18235121</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2000 Oct 13;103(2):211-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11057895</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer. 2018 Feb 19;17(1):48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29455673</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2017 Mar 9;376(10):917-927</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28273028</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Onco Targets Ther. 2018 Oct 17;11:7095-7107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30410366</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Transl Oncol. 2017 Oct;19(10):1175-1182</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28409322</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2019 Dec 1;30(12):1884-1901</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31566661</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Jan 1;372(1):30-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25399551</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Sci. 2019 Oct;110(10):3244-3254</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31368625</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2018 Oct 15;9(1):4274</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30323337</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Cancer Res. 2017 May 01;7(5):1016-1036</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28560055</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Soc Trans. 2012 Feb;40(1):139-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22260680</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogenesis. 2019 Oct 9;8(10):59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31597912</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer. 2018 Feb 19;17(1):43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29455663</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am Soc Clin Oncol Educ Book. 2018 May 23;38:184-187</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30231313</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Development. 2016 Sep 1;143(17):3050-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27578176</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2009 Dec 15;15(24):7510-7518</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20008851</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2018 Jan;17(1):3-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29295962</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2019 May;30(5):863-870</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31987360</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2019 Dec 1;30(12):1856-1883</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31549998</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Pharmacol. 2018 Sep;175(17):3504-3515</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29908090</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30285222</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2014 Jul 26;384(9940):319-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24768112</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Res. 2018 Oct;136:97-107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30170190</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Feb 12;372(7):621-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25671254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2015 Sep;26 Suppl 5:v126-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26314774</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chonnam Med J. 2017 Sep;53(3):173-177</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29026704</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Pharm Biotechnol. 2016;17(14):1246-1267</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27774890</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Biol Sci. 2018 Feb 5;14(2):204-216</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29483838</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2018 Aug 1;29(8):1634-1657</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30032243</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2019 May 1;30(5):706-720</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30788497</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:98-107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29888050</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Transl Oncol. 2016 Sep;18(9):893-900</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26597115</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Med. 2016 Jul;38(1):3-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27245147</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Syst Biol. 2005;1:2005.0010</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16729045</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2018 Jul 5;132(1):67-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29784639</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Pharmacol Sin. 2017 May;38(5):614-622</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28344323</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Anticancer Ther. 2015;15(8):943-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26098949</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Signal. 2001 Nov;13(11):777-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11583913</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Oncol. 2019 Feb 3;2019:5245034</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30853982</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Biotechnol. 2019 Sep;37(9):1038-1040</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31477924</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2020 Apr 10;38(11):1154-1163</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31961766</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2013 Mar 1;19(5):1225-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23307859</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'